TABLE 3

Post-Index Overlapping Insulin Use With U-500R

Overlapping of U-500R Claims and Claims for Other Insulins, daysN = 1,582.
01,172 (74.1)
≥1410 (25.9)
 ≥15–29  359 (22.7)
  ≥30–44   258 (16.3)
   ≥45–59    148 (9.4)
     ≥60     120 (7.6)
  • Data are n (%).